期刊文献+

免疫净化疗法的研究进展

下载PDF
导出
出处 《华北国防医药》 2009年第3期77-79,共3页 Medical Journal of Beijing Military Region
  • 相关文献

参考文献20

  • 1Nafar M,Farrokhi F,Hemati K,et al.Plasmapheresis in the treatment of early acute kidney allograft dysfunction[J].Experimental and clinical transplantation,2006,4(2):506-509.
  • 2Sotiropoulos G C,Lang H,Herget Rosenthal S,et al.Salvage plasmapheresis for small-for-size syndrome following hepatic resection for colorectal liver metastases[J].Int J Colorectal Dis,2008,23(5):55.
  • 3Yeh J H,Chien P J,Hsueh Y M,et al.Changes in the lymphocyte subset after double-fihration plasmapheresis[J].Am J Clin Pathol,2007,128 (6):940-944.
  • 4Vlasenko A N,Vorob'ev A A,Matveev SIu.Clinical effectiveness of plasmapheresis and lymphocytoplasmapheresis in patients with systemic scleroderma[J].Klin Med (Mosk),1992,70 (2):57-61.
  • 5张学武,贾园,穆荣.免疫净化对难治性系统性红斑狼疮治疗效果的观察[J].中国血液净化,2003,2(10):540-542. 被引量:4
  • 6李碧娟,杨晓苏,陈冰,彭晶晶,彭金艳,舒象武.淋巴血浆置换抢救重症肌无力危象的应用研究[J].中国输血杂志,2006,19(6):469-470. 被引量:8
  • 7Ronco C,Brendolan A,Dan M,et al.Immune adsorption in spesis[J].Kidney Int,2000,58 (76):148-149.
  • 8Marshall J C.Clinical trials of mediator-directed therapy in sepsis:what have we learned?[J].Intensive Care Med,2000,26(Suppl 1):75-83.
  • 9Formica M,lnguaggiato P,Bainotti S,et al.Coupled plasma filtration adsorption[J].Contrib Nephrol,2007 (156):405-410.
  • 10Nakamura T,Kawagoe Y,Suzuki T,et al.Polymyxin B-immobilized fiber hemoperfusion with the PMX-05R column in elderly patients suffering from septic shock[J].Am J Med Sci,2007,334 (4):244-247.

二级参考文献27

  • 1肖波.重症肌无力发病机制的研究进展[J].中华神经科杂志,2005,38(4):217-219. 被引量:4
  • 2[1]DJ Wallace. Apheresis for lupus erthematosus. Lupus,1999,8:174-180
  • 3[2]Hanly JG, Hong C, Zayed E, et al. Immunomodulating effects of synchro nosed plasmspheresis and intravenous bolus cyclophosphamide in systemic lupus erythematosus. Lupus,1995,4(6):457-463
  • 4[3]Csipo I,Kiss E,soltesz P, et al. Effect of plasmapheresis on ligand binding capacity and expression of erythrocyte complement receptor typeⅠ(CR Ⅰ)of patient with systemic lupus erythematosus. Clin Exp Immunol,1999,118(3):458-46 4
  • 5[4]Suzuki K, Taman J, Matsuki Y, et al.Anti-DNA antidodiey kinetics during in vivo apheresis in systemic lupus erythematosus patients and in an in vitro apheresis model.J Clin apheresis,1996,11(4):211-216
  • 6[5]Jones JV. Response to apheresis:problems of assessment in immune dis ease. Clin Nephrol,1986,26 (Suppl 1):70-75
  • 7[6]Csipo I,kavai M, kiss E, et al. Serum complememt activation of SLE pa tients during plasmapheresis. Autoimmunity,1997,25(3):139-146
  • 8[7]Funauchi M, Ikoma S, Enomoto H, et al. High affinity anti DNA antibody parallels clinical course of immunoadsorption therapy for systemic lupus erythematosus. Intern Med,1996,35(5):367-372
  • 9[8]Schiel R, Bambauer R, Lataza R, et al. Cycloporin and plasmapheresis in treatment of progressivae systemic lupus erythematosus.Transfus Sci,1997, 18 ( 1):91-97
  • 10[9]Suzuki K, Hara M,Harigar M,et al.Continous removal of anti-DNA antibody using a new extracorporeal immunoadsorption system in patients with systemic lupus erythematosus. Arthitis Rheum,1991,34(12):1546-1552

共引文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部